Nefazodone hydrochloride (trade name Serzone) is an antidepressant drug marketed by Bristol-Myers Squibb. Its sale was discontinued in 2003 in some countries, due to the small possibility of hepatic (liver) injury, which could lead to the need for a liver transplant, or even death. The incidence of severe liver damage is approximately one in 250,000 to 300,000 patient-years. On May 20, 2004, Bristol-Myers Squibb discontinued the sale of Serzone in the United States. Several generic formulations of nefazodone are still available.

While the Food and Drug Administration and many doctors say it's safe, a growing contingent of consumers thinks the additive is dangerous if not deadly. One lawmaker is bringing the debate to the Capitol.

Bayer HealthCare announced, following consultation with the United States Food and Drug Administration (FDA), that it will withdraw the current liquid formulation of Leukine marketed in the US.

The American Society of Plastic Surgeons (ASPS) addressed concerns regarding the use of botulinum toxin products and adverse events following a recent petition from a consumer group.On January 23, Public Citizen requested the U.S. Food and Drug Administration (FDA) implement labeling changes and a written communication to physicians.

Sushi from 5 of the 20 places had mercury levels so high that the Food and Drug Administration could take legal action to remove the fish from the market. The sushi was bought by The New York Times in October. Unfortunately, the NY Times doesn’t really go into how that mercury got into the tuna in the first place. ....

"All reptiles (turtles, lizards, snakes) and amphibians (frogs, salamanders), are commonly contaminated with Salmonella," says Joseph C. Paige, D.V.M., a Consumer Safety Officer in the Food and Drug Administration's Center for Veterinary Medicine.